Log inSign up
BiotechTV
2,461 posts
Image
user avatar
BiotechTV
@BiotechTV
Daily biotech news, content, and exclusive interviews.
Kendall Square
biotechtv.com
Joined May 2023
41
Following
11.5K
Followers
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 17
    ๐Ÿ๐ŸŽ๐ฑ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ: @10xGenomics and @ClevelandClinic will collaborate to use single cell and spatial technologies to research diagnostics for bladder cancer. The goal is to match the wave of new modalities to the right tumor markers. More: investors.10xgenomics.com/news/news-detaโ€ฆ
    Image
    00:00
    Paid partnership
    1.6K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 16
    ๐Ÿ๐ŸŽ๐ฑ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ: During the 2026 @humancellatlas General Meeting in Boston today, @10xGenomics Co-Founder & CEO Serge Saxonov showed us the companyโ€™s new single cell spatial biology platform, Atera. Learn more: 10xgenomics.com/platforms/atera
    Image
    00:00
    Paid partnership
    2K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 16
    ๐Ÿ๐ŸŽ๐ฑ ๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ: At the 2026 @humancellatlas General Meeting in Boston, @10xGenomics is showing researchers its newest tool, Atera, which sets a new standard for single cell spatial biology. Full video: biotechtv.com/post/human-celโ€ฆ
    Image
    00:00
    Paid partnership
    2.2K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 16
    ๐๐ž๐ฐ ๐’๐ฉ๐จ๐ง๐ฌ๐จ๐ซ ๐€๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ: Today BiotechTV welcomes a new sponsor for 2026, @10xGenomics. We are thrilled to partner with this global leader of innovative sequencing technologies, and we are grateful for their support!
    Image
    1.4K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 15
    ๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, @schroederthilo describes his investment philosophy and focus on precision oncology. Full video: biotechtv.com/post/bioventurโ€ฆ
    Image
    00:00
    13K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 14
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: After presenting early in vivo CAR-T data showing promising results in 6 patients at #EHA2026, @LegendBiotech CEO Ying Huang discusses the future of these types of treatments. $LEGN Watch the full interview: biotechtv.com/post/legend-biโ€ฆ
    Image
    00:00
    3.8K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 14
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @LegendBiotech CEO Ying Huang discusses the company's late-breaking in vivo CAR-T #EHA2026 presentation showing a 6/6 overall response and 5/6 complete response at the highest dose level in NHL. $LEGN Watch the full interview: biotechtv.com/post/legend-biโ€ฆ
    Image
    00:00
    3.5K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 13
    ๐–๐ž๐ž๐ค ๐ข๐ง ๐‘๐ž๐ฏ๐ข๐ž๐ฐ: With M&A news like GSK's $10.6B acquisition of Nuvalent and more positive clinical trial data in pancreatic cancer, biotech mostly outperformed the broader market this week. $TNGX $NUVL $ELVN $HUMA $CNTX Link to video: biotechtv.com/post/biotech-mโ€ฆ
    Image
    00:00
    2.4K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 13
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: With its myelofibrosis data now out, @Karyopharm's next big event is a key trial readout in endometrial cancer that is scheduled for mid-year. CEO Richard Paulson previews it for us. $KPTI Watch the full interview: biotechtv.com/post/karyopharโ€ฆ
    Image
    00:00
    6.3K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 13
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @Karyopharm is hoping to add two new indications for selinexor over the near term - they just presented the phase 3 for the first one, myelofibrosis, at ASCO with an encore at #EHA2026. $KPTI Full video: biotechtv.com/post/karyopharโ€ฆ
    Image
    00:00
    3.2K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 12
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: Earlier this week, there was a high profile acquisition of a degrader-antibody conjugate company. @Nurix_Tx CEO Arthur Sands, who is also pioneer on this, describes the scientific idea behind it. $NRIX Watch the full interview: biotechtv.com/post/nurix-theโ€ฆ
    Image
    00:00
    3.8K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 12
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @Nurix_Tx CEO Arthur T. Sands discusses this week's big collaboration deal with Roche, and highlights the company's #EHA2026 data and broader platform. $NRIX Full video: biotechtv.com/post/nurix-theโ€ฆ
    Image
    00:00
    4.8K
  • user avatar
    BiotechTV
    @BiotechTV
    Jun 12
    ๐„๐‡๐€ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @CaribouBio's CEO Rachel Haurwitz on trying to convince Wall Street to see her vision on allogeneic CAR-T. #EHA2026 $CRBU See the full interview: biotechtv.com/post/caribou-bโ€ฆ
    Image
    00:00
    2.4K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|ยฉ 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement